AstraZeneca Plc Is Tougher Pfizer Inc. Target as Possible Bid Looms

Pfizer Inc. Celebrex brand heartburn medication is arranged for a photograph at a pharmacy in Princeton, Illinois, U.S., on Wednesday, Aug. 20, 2014. Pfizer Inc. isnt giving up on striking an overseas takeover to cut its tax rate and gain a new pipeline of drugs, even as the potential cost of acquiring AstraZeneca Plc rises. Photographer: Daniel Acker/Bloomberg via Getty Images
Pfizer Inc. Celebrex brand heartburn medication is arranged for a photograph at a pharmacy in Princeton, Illinois, U.S., on Wednesday, Aug. 20, 2014. Pfizer Inc. isnt giving up on striking an overseas takeover to cut its tax rate and gain a new pipeline of drugs, even as the potential cost of acquiring AstraZeneca Plc rises. Photographer: Daniel Acker/Bloomberg via Getty Images
AstraZeneca Plc Is Tougher Pfizer Inc. Target as Possible Bid Looms
PURCHASE A LICENSE
How can I use this image?
$575.00
CAD

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
453912486
Collection:
Bloomberg
Date created:
August 20, 2014
Upload date:
License type:
Release info:
Not released. More information
Source:
Bloomberg
Object name:
ASTRAZENECA PFIZER